...
Product Theater – CIMZIA® (certolizumab pegol): A Different Kind of Anti-TNF for Psoriatic Disease
June 8, 2019

Featuring Guest Faculty, Robert Casquejo, PA-C For Saturday morning’s product theater, Robert Casquejo, PA-C, presented information on the medication Cimzia. Cimzia is an FDA approved biologic treatment for adults with moderate to severe psoriasis and for treatment of adults with psoriatic arthritis. Cimzia is an injectable TNF blocker medication. According to Mr. Casquejo, Cimzia has …

...
Do PDE4 Inhibitors Work as Treatment for Hidradenitis Suppurativa?
January 17, 2019

Hidradenitis suppurativa (HS) is a chronic, autoinflammatory skin disorder that presents with painful, itchy, inflamed nodules, and abscesses. It affects about 1% of the population, more frequently in females, often first appearing in adolescence. First-line therapies include anti-inflammatory oral antibiotics, but more recently treatment with the biologic adalimumab has demonstrated clinically significant improvement in the …

...
How Safe and Effective are 5ARI to Treat Alopecia?
September 5, 2018

Frontal fibrosing alopecia (FFA) causes hair loss near the front of the head, and causes scarring due to inflammation as the hair follicles are destroyed. This condition, which mostly affects postmenopausal women, is challenging to treat, and studies have examined the off-label use of 5-alpha-reductase inhibitors (5ARI) as a possible option for more severe cases. …